share_log

Johnson & Johnson | 424B2: Prospectus

Johnson & Johnson | 424B2: Prospectus

强生 | 424B2：募资说明书
美股sec公告 ·  05/16 16:21
Moomoo AI 已提取核心信息
Johnson & Johnson (JNJ.US), a leading healthcare company, has announced the issuance of a series of senior unsecured notes under its existing shelf registration. The notes, denominated in euros, are offered in three tranches: €700 million at 3.200% due 2032, €800 million at 3.350% due 2036, and €1 billion at 3.550% due 2044. Interest on these notes will be paid annually beginning June 1, 2024. The notes are expected to be listed on the New York Stock Exchange and are intended to be used for general corporate purposes, which may include funding the acquisition of Shockwave Medical, Inc. The offering is managed by a consortium of banks, including J.P. Morgan, Citigroup, and Deutsche Bank, acting as joint book-running managers. The issuance is subject to customary closing conditions and is expected to settle on May 20, 2024.
Johnson & Johnson (JNJ.US), a leading healthcare company, has announced the issuance of a series of senior unsecured notes under its existing shelf registration. The notes, denominated in euros, are offered in three tranches: €700 million at 3.200% due 2032, €800 million at 3.350% due 2036, and €1 billion at 3.550% due 2044. Interest on these notes will be paid annually beginning June 1, 2024. The notes are expected to be listed on the New York Stock Exchange and are intended to be used for general corporate purposes, which may include funding the acquisition of Shockwave Medical, Inc. The offering is managed by a consortium of banks, including J.P. Morgan, Citigroup, and Deutsche Bank, acting as joint book-running managers. The issuance is subject to customary closing conditions and is expected to settle on May 20, 2024.
领先的医疗保健公司强生公司（JNJ.US）宣布根据其现有货架注册发行一系列优先无担保票据。这些票据以欧元计价，分三批发行：7亿欧元，利率3.200％，2032年到期；8亿欧元，2036年到期，3.350％；10亿欧元，2044年到期，3.550％。从2024年6月1日起，这些票据的利息将每年支付。这些票据预计将在纽约证券交易所上市，用于一般公司用途，其中可能包括为收购Shockwave Medical, Inc.提供资金。此次发行由包括摩根大通、花旗集团和德意志银行在内的银行财团管理，担任联席账面管理人。本次发行受惯例成交条件的约束，预计将于2024年5月20日结算。
领先的医疗保健公司强生公司（JNJ.US）宣布根据其现有货架注册发行一系列优先无担保票据。这些票据以欧元计价，分三批发行：7亿欧元，利率3.200％，2032年到期；8亿欧元，2036年到期，3.350％；10亿欧元，2044年到期，3.550％。从2024年6月1日起，这些票据的利息将每年支付。这些票据预计将在纽约证券交易所上市，用于一般公司用途，其中可能包括为收购Shockwave Medical, Inc.提供资金。此次发行由包括摩根大通、花旗集团和德意志银行在内的银行财团管理，担任联席账面管理人。本次发行受惯例成交条件的约束，预计将于2024年5月20日结算。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息